CLINICAL_TRIALS
trial_result
· 2020-10-23
Clinical Trial Update: Cholinesterase Inhibitor Discontinuation [Phase 2, Phase 3]
Summary
A completed Phase 2/Phase 3 clinical trial update on discontinuation of a cholinesterase inhibitor for dementia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: VA Office of Research and Development | Conditions: Dementia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-10-23